Huber Capital Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Sell
16,890
-12,119
-42% -$864K 0.19% 59
2026
Q2
$2M Sell
29,009
-6,906
-19% -$459K 0.29% 55
2026
Q1
$2.23M Sell
35,915
-925
-3% -$58.3K 0.34% 51
2025
Q4
$2.06M Sell
36,840
-11,012
-23% -$638K 0.3% 51
2025
Q3
$3.01M Sell
47,852
-7,496
-14% -$443K 0.48% 44
2025
Q2
$3.15M Buy
55,348
+15,529
+39% +$845K 0.54% 44
2025
Q1
$2.23M Buy
39,819
+11,149
+39% +$668K 0.42% 49
2024
Q4
$1.76M Buy
+28,670
New +$1.85M 0.35% 57

Other funds holding UTMD

Huber Capital Management's UTMD Position: Q3 2026 in Review

Huber Capital Management reduced its Utah Medical Products (UTMD) stake by 42% in Q3 2026, selling an estimated $864K and leaving 16,890 shares worth $1.25M. The position accounts for 0.19% of the portfolio, ranked #59.

Huber Capital Management first reported a position in UTMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.15M in Q2 2025. 109 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Huber Capital Management held 16,890 shares of Utah Medical Products worth $1.25M as of Q3 2026.
  • Huber Capital Management sold 12,119 Utah Medical Products shares in Q3 2026, an estimated $864K.
  • Utah Medical Products made up 0.19% of Huber Capital Management's portfolio in Q3 2026, its #59 holding.
  • Huber Capital Management first reported a position in Utah Medical Products in Q4 2024 and has held it in 8 quarters since.
  • Huber Capital Management's Utah Medical Products position peaked at $3.15M in Q2 2025.
  • 109 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Huber Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.